catalent glp-1 Novo Nordisk tackles supply issues with $11bn deal Catalent releases Q1 fiscal results

Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome

When a patient's blood sugar levels are high, GLP-1 drugs send signals to their pancreas to secrete more insulin but the hormone-mimicking doesn't stop there

Semaglutide and Tirzepatide are FDA-approved for chronic weight management and have a well-established safety profile backed by years of clinical trials

If you experience unusual nausea, dizziness, or blood sugar fluctuations after an early injection, contact your provider

Trichloroethanol also undergoes glucuronidation to produce an inactive metabolism

Our team of licensed medical professionals provides access to IV nutrient therapy and vitamin injections designed for efficient nutrient delivery directly into the bloodstream